[
  {
    "ts": "2026-01-30T00:26:00+00:00",
    "headline": "Pfizer CEO says he used ‘emotional blackmail’ to get employees to achieve impossible goals during COVID-19",
    "summary": "Albert Bourla admitted to going to extreme lengths to “save the world” and get the vaccines out faster during the COVID-19 pandemic.",
    "url": "https://finance.yahoo.com/news/pfizer-ceo-says-used-emotional-002600936.html",
    "source": "Fortune",
    "provider": "yfinance",
    "raw": {
      "id": "45af5c5a-700c-329d-9ad8-87c958ca2228",
      "content": {
        "id": "45af5c5a-700c-329d-9ad8-87c958ca2228",
        "contentType": "STORY",
        "title": "Pfizer CEO says he used ‘emotional blackmail’ to get employees to achieve impossible goals during COVID-19",
        "description": "",
        "summary": "Albert Bourla admitted to going to extreme lengths to “save the world” and get the vaccines out faster during the COVID-19 pandemic.",
        "pubDate": "2026-01-30T00:26:00Z",
        "displayTime": "2026-01-30T00:26:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/fortune_175/05dc3dcf7e1b62c0bb05b371b03e35c5",
          "originalWidth": 2048,
          "originalHeight": 1152,
          "caption": "On Fortune's Titans and Disruptors of Industry podcast, Pfizer CEO Albert Bourla shared his team-motivating strategies.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/xryqJth391gm8EqnD65fUw--~B/aD0xMTUyO3c9MjA0ODthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/fortune_175/05dc3dcf7e1b62c0bb05b371b03e35c5.cf.webp",
              "width": 2048,
              "height": 1152,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/BxSY7MVdUc1Y08fAg7sabQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/fortune_175/05dc3dcf7e1b62c0bb05b371b03e35c5.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Fortune",
          "url": "http://fortune.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-ceo-says-used-emotional-002600936.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-ceo-says-used-emotional-002600936.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-30T07:51:00+00:00",
    "headline": "AstraZeneca Strikes Multibillion-Dollar Obesity Deal With China’s CSPC",
    "summary": "The agreement to gain rights outside of China to a portfolio of experimental obesity and diabetes drugs could be valued at billions of dollars.",
    "url": "https://www.wsj.com/health/pharma/astrazeneca-strikes-multibillion-dollar-obesity-deal-with-chinas-cspc-81830497?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "99c64a7e-e4a1-347d-9ef5-be0276d3ad99",
      "content": {
        "id": "99c64a7e-e4a1-347d-9ef5-be0276d3ad99",
        "contentType": "STORY",
        "title": "AstraZeneca Strikes Multibillion-Dollar Obesity Deal With China’s CSPC",
        "description": "",
        "summary": "The agreement to gain rights outside of China to a portfolio of experimental obesity and diabetes drugs could be valued at billions of dollars.",
        "pubDate": "2026-01-30T07:51:00Z",
        "displayTime": "2026-01-30T07:51:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/99c64a7e-e4a1-347d-9ef5-be0276d3ad99/astrazeneca-strikes.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/b548ddc70059718c5f032dbd1bbc5353",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/dguVajvjbuUaLrMArJPZcg--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/b548ddc70059718c5f032dbd1bbc5353.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/77NLSWy3dAWrjld75.ROMA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/b548ddc70059718c5f032dbd1bbc5353.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/health/pharma/astrazeneca-strikes-multibillion-dollar-obesity-deal-with-chinas-cspc-81830497?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AZN"
            },
            {
              "symbol": "AZNCF"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "RHHBF"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "ZLDPF"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-30T12:20:00+00:00",
    "headline": "3 Top Dividend Stocks Yielding More Than 4% to Buy Hand Over Fist This Year",
    "summary": "All three can provide you with solid, consistent income.",
    "url": "https://www.fool.com/investing/2026/01/30/4-top-dividend-stocks-yielding-more-than-4-to-buy/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "5bc71bc8-8c0f-3c38-b206-fdc34b3a17ce",
      "content": {
        "id": "5bc71bc8-8c0f-3c38-b206-fdc34b3a17ce",
        "contentType": "STORY",
        "title": "3 Top Dividend Stocks Yielding More Than 4% to Buy Hand Over Fist This Year",
        "description": "",
        "summary": "All three can provide you with solid, consistent income.",
        "pubDate": "2026-01-30T12:20:00Z",
        "displayTime": "2026-01-30T12:20:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/fb26a1a78705ca1ec5d89bf423db100e",
          "originalWidth": 1400,
          "originalHeight": 828,
          "caption": "Pharmacist talking to patient.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Xrp4oS2pOUbW5k1KobPDRw--~B/aD04Mjg7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/fb26a1a78705ca1ec5d89bf423db100e.cf.webp",
              "width": 1400,
              "height": 828,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/zdUSZDjZ4.HCHd8DgrgaRg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/fb26a1a78705ca1ec5d89bf423db100e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2026/01/30/4-top-dividend-stocks-yielding-more-than-4-to-buy/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/3-top-dividend-stocks-yielding-122000637.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "MPW"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-30T10:31:00+00:00",
    "headline": "AstraZeneca Strikes Obesity Multibillion-Dollar Deal With China’s CSPC Pharmaceuticals",
    "summary": "The agreement to gain rights outside of China to a portfolio of early-stage experimental obesity and diabetes drugs could be valued at billions of dollars.",
    "url": "https://www.wsj.com/health/pharma/astrazeneca-strikes-multibillion-dollar-obesity-deal-with-chinas-cspc-81830497?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "99c64a7e-e4a1-347d-9ef5-be0276d3ad99",
      "content": {
        "id": "99c64a7e-e4a1-347d-9ef5-be0276d3ad99",
        "contentType": "STORY",
        "title": "AstraZeneca Strikes Obesity Multibillion-Dollar Deal With China’s CSPC Pharmaceuticals",
        "description": "",
        "summary": "The agreement to gain rights outside of China to a portfolio of early-stage experimental obesity and diabetes drugs could be valued at billions of dollars.",
        "pubDate": "2026-01-30T10:31:00Z",
        "displayTime": "2026-01-30T10:31:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/99c64a7e-e4a1-347d-9ef5-be0276d3ad99/astrazeneca-strikes-obesity.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/b548ddc70059718c5f032dbd1bbc5353",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/dguVajvjbuUaLrMArJPZcg--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/b548ddc70059718c5f032dbd1bbc5353.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/77NLSWy3dAWrjld75.ROMA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/b548ddc70059718c5f032dbd1bbc5353.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/health/pharma/astrazeneca-strikes-multibillion-dollar-obesity-deal-with-chinas-cspc-81830497?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AZN"
            },
            {
              "symbol": "RHHBF"
            },
            {
              "symbol": "AZNCF"
            },
            {
              "symbol": "RHHBY"
            },
            {
              "symbol": "RHHVF"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MTSR"
            },
            {
              "symbol": "ZLDPF"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-30T12:58:00+00:00",
    "headline": "Should You Buy, Sell or Hold Pfizer Stock Ahead of Q4 Earnings?",
    "summary": "PFE heads into Q4 earnings with strong oncology and Vyndaqel demand, but IRA headwinds, COVID declines and falling estimates weigh on the outlook",
    "url": "https://finance.yahoo.com/news/buy-sell-hold-pfizer-stock-125800503.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "6a8b2f7a-f419-3340-9e57-fcd4c2956358",
      "content": {
        "id": "6a8b2f7a-f419-3340-9e57-fcd4c2956358",
        "contentType": "STORY",
        "title": "Should You Buy, Sell or Hold Pfizer Stock Ahead of Q4 Earnings?",
        "description": "",
        "summary": "PFE heads into Q4 earnings with strong oncology and Vyndaqel demand, but IRA headwinds, COVID declines and falling estimates weigh on the outlook",
        "pubDate": "2026-01-30T12:58:00Z",
        "displayTime": "2026-01-30T12:58:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/1e2f63f10f05b0390ba8b63bd4ef031c",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YqcOBKMNrThKvJSga1KIbw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/1e2f63f10f05b0390ba8b63bd4ef031c.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/_Vj9Bix098SQE5mY9G0P2w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/1e2f63f10f05b0390ba8b63bd4ef031c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/buy-sell-hold-pfizer-stock-125800503.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/buy-sell-hold-pfizer-stock-125800503.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "NVO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-30T12:50:00+00:00",
    "headline": "Buy, Sell or Hold MRK Stock: Key Factors to Watch Before Q4 Earnings",
    "summary": "Merck heads into Q4 earnings with strong Keytruda demand and new product launches, but declining estimates and M&A costs cloud the near-term outlook.",
    "url": "https://finance.yahoo.com/news/buy-sell-hold-mrk-stock-125000821.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "be49aea0-3735-3948-bc45-d360e9bf96cd",
      "content": {
        "id": "be49aea0-3735-3948-bc45-d360e9bf96cd",
        "contentType": "STORY",
        "title": "Buy, Sell or Hold MRK Stock: Key Factors to Watch Before Q4 Earnings",
        "description": "",
        "summary": "Merck heads into Q4 earnings with strong Keytruda demand and new product launches, but declining estimates and M&A costs cloud the near-term outlook.",
        "pubDate": "2026-01-30T12:50:00Z",
        "displayTime": "2026-01-30T12:50:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/7813b4a575be05490cc210e943a2c6f1",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/huVQAxApMqB.EnhvDFmmKQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/7813b4a575be05490cc210e943a2c6f1.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/AOhBEAisdCF50xeLb4f6kA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/7813b4a575be05490cc210e943a2c6f1.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/buy-sell-hold-mrk-stock-125000821.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/buy-sell-hold-mrk-stock-125000821.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "CDTX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-30T12:17:00+00:00",
    "headline": "AstraZeneca Strikes Multibillion-Dollar Obesity Deal With China’s CSPC Pharmaceuticals",
    "summary": "The agreement to gain rights outside of China to a portfolio of early-stage experimental obesity and diabetes drugs could be valued at billions of dollars.",
    "url": "https://www.wsj.com/health/pharma/astrazeneca-strikes-multibillion-dollar-obesity-deal-with-chinas-cspc-81830497?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "99c64a7e-e4a1-347d-9ef5-be0276d3ad99",
      "content": {
        "id": "99c64a7e-e4a1-347d-9ef5-be0276d3ad99",
        "contentType": "STORY",
        "title": "AstraZeneca Strikes Multibillion-Dollar Obesity Deal With China’s CSPC Pharmaceuticals",
        "description": "",
        "summary": "The agreement to gain rights outside of China to a portfolio of early-stage experimental obesity and diabetes drugs could be valued at billions of dollars.",
        "pubDate": "2026-01-30T12:17:00Z",
        "displayTime": "2026-01-30T12:17:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/99c64a7e-e4a1-347d-9ef5-be0276d3ad99/astrazeneca-strikes.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/b548ddc70059718c5f032dbd1bbc5353",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/dguVajvjbuUaLrMArJPZcg--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/b548ddc70059718c5f032dbd1bbc5353.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/77NLSWy3dAWrjld75.ROMA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/b548ddc70059718c5f032dbd1bbc5353.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/health/pharma/astrazeneca-strikes-multibillion-dollar-obesity-deal-with-chinas-cspc-81830497?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AZN"
            },
            {
              "symbol": "AZNCF"
            },
            {
              "symbol": "RHHBY"
            },
            {
              "symbol": "RHHVF"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MTSR"
            },
            {
              "symbol": "RHHBF"
            },
            {
              "symbol": "ZLDPF"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-30T14:00:04+00:00",
    "headline": "Investors Heavily Search Pfizer Inc. (PFE): Here is What You Need to Know",
    "summary": "Zacks.com users have recently been watching Pfizer (PFE) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",
    "url": "https://finance.yahoo.com/news/investors-heavily-search-pfizer-inc-140004078.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "03da4b4f-3806-33b2-9abc-bd1978f31f8a",
      "content": {
        "id": "03da4b4f-3806-33b2-9abc-bd1978f31f8a",
        "contentType": "STORY",
        "title": "Investors Heavily Search Pfizer Inc. (PFE): Here is What You Need to Know",
        "description": "",
        "summary": "Zacks.com users have recently been watching Pfizer (PFE) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",
        "pubDate": "2026-01-30T14:00:04Z",
        "displayTime": "2026-01-30T14:00:04Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/b95cfdd8768bc3c4620e666dbcb0b248",
          "originalWidth": 900,
          "originalHeight": 467,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/EqfP7bv9QEr5Eo0h619oww--~B/aD00Njc7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/b95cfdd8768bc3c4620e666dbcb0b248.cf.webp",
              "width": 900,
              "height": 467,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/vJLygzZiYik0.mXQcVdmSw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/b95cfdd8768bc3c4620e666dbcb0b248.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/investors-heavily-search-pfizer-inc-140004078.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/investors-heavily-search-pfizer-inc-140004078.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-30T13:49:00+00:00",
    "headline": "Will BMY's Oncology Collaborations Drive Its Next Growth Phase?",
    "summary": "BMY boosts its oncology pipeline with a Janux deal on tumor-activated therapy, alongside encouraging pumitamig data and multiple cancer collaborations.",
    "url": "https://finance.yahoo.com/news/bmys-oncology-collaborations-drive-next-134900674.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "9f8b8207-24f5-3073-a233-63f5d7e108fd",
      "content": {
        "id": "9f8b8207-24f5-3073-a233-63f5d7e108fd",
        "contentType": "STORY",
        "title": "Will BMY's Oncology Collaborations Drive Its Next Growth Phase?",
        "description": "",
        "summary": "BMY boosts its oncology pipeline with a Janux deal on tumor-activated therapy, alongside encouraging pumitamig data and multiple cancer collaborations.",
        "pubDate": "2026-01-30T13:49:00Z",
        "displayTime": "2026-01-30T13:49:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/52b6d392b63705aefb517365eab38a95",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/AZ1NFKr1Arip4UWINeWStw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/52b6d392b63705aefb517365eab38a95.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/zL5_evNVQm1N5N.bc6WldQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/52b6d392b63705aefb517365eab38a95.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bmys-oncology-collaborations-drive-next-134900674.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bmys-oncology-collaborations-drive-next-134900674.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JANX"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "MSFT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-30T13:39:00+00:00",
    "headline": "CRMD Down 31% in a Month: Is This an Indication to Sell the Stock?",
    "summary": "CorMedix sinks 31% in a month after cautious 2026 guidance for DefenCath points to slower adoption and pricing pressure, likely souring investor sentiment.",
    "url": "https://finance.yahoo.com/news/crmd-down-31-month-indication-133900994.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "dcc08d1f-aca0-35d8-becb-29f64b75a992",
      "content": {
        "id": "dcc08d1f-aca0-35d8-becb-29f64b75a992",
        "contentType": "STORY",
        "title": "CRMD Down 31% in a Month: Is This an Indication to Sell the Stock?",
        "description": "",
        "summary": "CorMedix sinks 31% in a month after cautious 2026 guidance for DefenCath points to slower adoption and pricing pressure, likely souring investor sentiment.",
        "pubDate": "2026-01-30T13:39:00Z",
        "displayTime": "2026-01-30T13:39:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/41b7bdd28f63138df08f17b665d3589a",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/EzN04L.MG5n2SiOn76bXjg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/41b7bdd28f63138df08f17b665d3589a.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/1EIdoTL1xBchT1nrSboC2Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/41b7bdd28f63138df08f17b665d3589a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/crmd-down-31-month-indication-133900994.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/crmd-down-31-month-indication-133900994.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CRMD"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-30T16:08:24+00:00",
    "headline": "Eli Lilly to build $3.5 billion Pennsylvania plant in US manufacturing push",
    "summary": "WASHINGTON, Jan 30 (Reuters) - Eli Lilly announced on Friday that it will build a pharmaceutical manufacturing facility in Pennsylvania, its fourth new site in an effort to expand U.S. production and",
    "url": "https://finance.yahoo.com/news/eli-lilly-build-3-5-160649482.html",
    "source": "Reuters",
    "provider": "yfinance",
    "raw": {
      "id": "c713a3ef-d331-31a2-99ba-4714b7489071",
      "content": {
        "id": "c713a3ef-d331-31a2-99ba-4714b7489071",
        "contentType": "STORY",
        "title": "Eli Lilly to build $3.5 billion Pennsylvania plant in US manufacturing push ",
        "description": "",
        "summary": "WASHINGTON, Jan 30 (Reuters) - Eli Lilly announced on Friday that it will build a pharmaceutical manufacturing facility in Pennsylvania, its fourth new site in an effort to expand U.S. production and",
        "pubDate": "2026-01-30T16:08:24Z",
        "displayTime": "2026-01-30T16:08:24Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/reuters.com/a88ecd38953893af426480199a607e70",
          "originalWidth": 800,
          "originalHeight": 534,
          "caption": "FILE PHOTO: Eli Lilly logo is shown on one of the company's offices in San Diego, California, U.S., September 17, 2020.   REUTERS/Mike Blake/File Photo",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/MKiT0fyZ2nkT.Au0ZZjn_w--~B/aD01MzQ7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/a88ecd38953893af426480199a607e70.cf.webp",
              "width": 800,
              "height": 534,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/nFw48OXamu8W4xPWAnKMHg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/a88ecd38953893af426480199a607e70.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Reuters",
          "url": "https://www.reuters.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-build-3-5-160649482.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-build-3-5-160649482.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-30T18:22:11+00:00",
    "headline": "‘We’ll save the world from cancer’: Inside Pfizer CEO’s $23 billion post‑COVID bet on oncology",
    "summary": "\"The winners in life are differentiated from the losers in life because the winners never fall,\" Albert Bourla says. \"The winners always stand up again.\"",
    "url": "https://finance.yahoo.com/news/ll-save-world-cancer-inside-182211069.html",
    "source": "Fortune",
    "provider": "yfinance",
    "raw": {
      "id": "4860b832-cab3-36c2-b634-b756518be709",
      "content": {
        "id": "4860b832-cab3-36c2-b634-b756518be709",
        "contentType": "STORY",
        "title": "‘We’ll save the world from cancer’: Inside Pfizer CEO’s $23 billion post‑COVID bet on oncology",
        "description": "",
        "summary": "\"The winners in life are differentiated from the losers in life because the winners never fall,\" Albert Bourla says. \"The winners always stand up again.\"",
        "pubDate": "2026-01-30T18:22:11Z",
        "displayTime": "2026-01-30T18:22:11Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/fortune_175/2b14416383c9ae6ae3b3d8e951b4ff99",
          "originalWidth": 2048,
          "originalHeight": 1152,
          "caption": "Fortune Editor-in-Chief Alyson Shontell interviews Pfizer CEO Albert Bourla.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/6NDXtLlniBPBiu7DplHWuQ--~B/aD0xMTUyO3c9MjA0ODthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/fortune_175/2b14416383c9ae6ae3b3d8e951b4ff99.cf.webp",
              "width": 2048,
              "height": 1152,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/hY24vFXFqSs9dkdm9LfeBQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/fortune_175/2b14416383c9ae6ae3b3d8e951b4ff99.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Fortune",
          "url": "http://fortune.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/ll-save-world-cancer-inside-182211069.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/ll-save-world-cancer-inside-182211069.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]